Page 58 - Lipids News Today

Researchers in Germany have solved the mystery of what prevents alveolar macrophages from developing properly: the transcription factor C/EBPß.

The government should consider implementing reforms in the information and communications technology sector, including strengthening the role of the National Telecommunications Commission as a regulator, to enable more people to gain access to internet services, according to state think tank Philippine Institute for Development Studies.

New discovery on the causes of PAP lung disease can also offer solutions for treating obesity and heart disease. The research group of Associate Professor Alexander Mildner at the University of Turku, Finland, identified a genetic defect that causes the accumulation of lipids in the pulmonary alveoli.

If a secretion in the lungs’ alveoli is not cleared regularly, breathing difficulties can develop. In a study published in Science Immunology, a team led by Alexander Mildner and Achim Leutz has now explained the pivotal role of the transcription factor C/EBPb in this process.

Transcatheter edge-to-edge repairs were associated with lower mortality and hospitalization in an analysis of a large, international registry.

A new review of studies of cardiovascular imaging in individuals with HIV shows a large variation in findings, making conclusions difficult, but there are suggestions that myocardial fibrosis may play a role.

Researchers who reviewed 20 years of diet history and 30 years of physical and clinical measurements have found participants who ate walnuts early on in life showed a greater likelihood for being more physically active, having a higher quality diet, and experiencing a better heart disease risk profile as they aged into middle adulthood.

Obesity is a growing global health problem and its prevalence has tripled since 1975. More than 650 million people are affected by this condition worldwide, and 28% of people in Spain over 18 years of age have this complex pathology. Obesity is linked to conditions such as type II diabetes, cardiovascular disease, osteoarthritis, and certain forms of cancer.

In the largest worldwide study to examine how fish oil supplements might reduce the risk of fractures in men and women age 50 and over and age 55 and over, respectively, the VITAL trial did not find any benefit.

They take a range of forms and are an increasingly common clinical issue with the growing list of cancers for which the immunologic agents are indicated.